Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.89
0.26 (5.62%)
At close: Aug 15, 2025, 12:54 PM
5.62% (1D)
| Bid | 4.75 |
| Market Cap | 62.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.2M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -8.73 |
| Forward PE | 0.26 |
| Analyst | Buy |
| Ask | 5.79 |
| Volume | 341,217 |
| Avg. Volume (20D) | 747,656 |
| Open | 4.61 |
| Previous Close | 4.63 |
| Day's Range | 4.50 - 4.97 |
| 52-Week Range | 2.75 - 11.00 |
| Beta | 1.87 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Unicycive Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-29.85%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago
-8.89%
Unicycive Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split effective June 20, 2025.
